338 related articles for article (PubMed ID: 27227815)
1. Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C.
Matsuura K; De Giorgi V; Schechterly C; Wang RY; Farci P; Tanaka Y; Alter HJ
Hepatology; 2016 Sep; 64(3):732-45. PubMed ID: 27227815
[TBL] [Abstract][Full Text] [Related]
2. Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.
Matsuura K; Aizawa N; Enomoto H; Nishiguchi S; Toyoda H; Kumada T; Iio E; Ito K; Ogawa S; Isogawa M; Alter HJ; Tanaka Y
Open Forum Infect Dis; 2018 Nov; 5(11):ofy268. PubMed ID: 30443558
[TBL] [Abstract][Full Text] [Related]
3. The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis.
Lambrecht J; Verhulst S; Reynaert H; van Grunsven LA
Cells; 2019 Aug; 8(9):. PubMed ID: 31470644
[No Abstract] [Full Text] [Related]
4. Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury.
Singh AK; Rooge SB; Varshney A; Vasudevan M; Bhardwaj A; Venugopal SK; Trehanpati N; Kumar M; Geffers R; Kumar V; Sarin SK
Hepatology; 2018 May; 67(5):1695-1709. PubMed ID: 29194684
[TBL] [Abstract][Full Text] [Related]
5. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients.
Abdel-Al A; El-Ahwany E; Zoheiry M; Hassan M; Ouf A; Abu-Taleb H; Abdel Rahim A; El-Talkawy MD; Zada S
Virus Res; 2018 Jul; 253():135-139. PubMed ID: 29932949
[TBL] [Abstract][Full Text] [Related]
6. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
Trebicka J; Anadol E; Elfimova N; Strack I; Roggendorf M; Viazov S; Wedemeyer I; Drebber U; Rockstroh J; Sauerbruch T; Dienes HP; Odenthal M
J Hepatol; 2013 Feb; 58(2):234-9. PubMed ID: 23085648
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
[TBL] [Abstract][Full Text] [Related]
8. microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C.
Van Keuren-Jensen KR; Malenica I; Courtright AL; Ghaffari LT; Starr AP; Metpally RP; Beecroft TA; Carlson EW; Kiefer JA; Pockros PJ; Rakela J
Liver Int; 2016 Mar; 36(3):334-43. PubMed ID: 26189820
[TBL] [Abstract][Full Text] [Related]
9. The characterization of extracellular vesicles-derived microRNAs in Thai malaria patients.
Ketprasit N; Cheng IS; Deutsch F; Tran N; Imwong M; Combes V; Palasuwan D
Malar J; 2020 Aug; 19(1):285. PubMed ID: 32778117
[TBL] [Abstract][Full Text] [Related]
10. Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis.
Cai P; Mu Y; Olveda RM; Ross AG; Olveda DU; McManus DP
EBioMedicine; 2018 Nov; 37():334-343. PubMed ID: 30482723
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
[TBL] [Abstract][Full Text] [Related]
12. Plasma sphingolipids: potential biomarkers for severe hepatic fibrosis in chronic hepatitis C.
Li JF; Qu F; Zheng SJ; Ren F; Wu HL; Liu M; Ren JY; Chen Y; Duan ZP; Zhang JL
Mol Med Rep; 2015 Jul; 12(1):323-30. PubMed ID: 25695872
[TBL] [Abstract][Full Text] [Related]
13. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.
Shrivastava S; Petrone J; Steele R; Lauer GM; Di Bisceglie AM; Ray RB
Hepatology; 2013 Sep; 58(3):863-71. PubMed ID: 23390075
[TBL] [Abstract][Full Text] [Related]
15. miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway.
Li X; Zhang W; Xu K; Lu J
Pathol Res Pract; 2020 May; 216(5):152876. PubMed ID: 32089410
[TBL] [Abstract][Full Text] [Related]
16. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
[TBL] [Abstract][Full Text] [Related]
17. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.
Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M
Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.
Zhang Q; Xu M; Qu Y; Li Z; Zhang Q; Cai X; Lu L
Mol Med Rep; 2015 Oct; 12(4):5647-54. PubMed ID: 26299203
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.
Anadol E; Schierwagen R; Elfimova N; Tack K; Schwarze-Zander C; Eischeid H; Noetel A; Boesecke C; Jansen C; Dold L; Wasmuth JC; Strassburg CP; Spengler U; Rockstroh JK; Odenthal M; Trebicka J
Hepatology; 2015 Jan; 61(1):46-55. PubMed ID: 25125218
[TBL] [Abstract][Full Text] [Related]
20. Progression of fibrosis in chronic hepatitis C.
Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH
Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
